Literature DB >> 8482958

Association of HLA-Bw46DR9 combination with juvenile myasthenia gravis in Chinese.

W H Chen1, H C Chiu, R P Hseih.   

Abstract

One hundred and fifty two Chinese patients with myasthenia gravis in Taiwan were investigated for HLA-A, B, C and DR/DQ typing. HLA-Bw46 and DR9 frequencies were significantly increased in patients compared with the control group, and there was a decrease in DR3. Further analysis between different subgroups of patients showed Bw46 and DR9 were more significantly increased in the juvenile group than in the adult group. No single HLA allele was associated with either clinical type or thymic pathology, but there was an excess of BW46DR9 combination in both juvenile and ocular type patients. The Chinese population with myasthenia gravis is characterised by earlier age at onset, more ocular forms and less clinically severe illness than in whites, and these characteristics indicate a special subgroup that correlates with the strong Bw46DR9 association.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8482958      PMCID: PMC1014955          DOI: 10.1136/jnnp.56.4.382

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  19 in total

1.  [Single fiber electromyography in myasthenia gravis].

Authors:  H C Chiu
Journal:  Taiwan Yi Xue Hui Za Zhi       Date:  1988-05

2.  Association of HLA-DRw9 with myasthenia gravis in Chinese.

Authors:  H C Chiu; R P Hsieh; K H Hsieh; T P Hung
Journal:  J Immunogenet       Date:  1987 Aug-Oct

3.  Calculation of the electromyographic jitter.

Authors:  J Ekstedt; G Nilsson; E Stalberg
Journal:  J Neurol Neurosurg Psychiatry       Date:  1974-05       Impact factor: 10.154

4.  Association of HLA antigens with myasthenia gravis in Chinese on Taiwan.

Authors:  H C Chiu; R P Hsieh; K H Hsieh
Journal:  Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi       Date:  1990-02

5.  HLA class II antigens and DNA restriction fragment length polymorphism in myasthenia gravis in Japan.

Authors:  K Morita; J Moriuchi; H Inoko; K Tsuji; S Arimori
Journal:  Ann Neurol       Date:  1991-02       Impact factor: 10.422

6.  Clinical, pathological, HLA antigen and immunological evidence for disease heterogeneity in myasthenia gravis.

Authors:  D A Compston; A Vincent; J Newsom-Davis; J R Batchelor
Journal:  Brain       Date:  1980-09       Impact factor: 13.501

7.  Disease associations with complotypes, supratypes and haplotypes.

Authors:  R L Dawkins; F T Christiansen; P H Kay; M Garlepp; J McCluskey; P N Hollingsworth; P J Zilko
Journal:  Immunol Rev       Date:  1983       Impact factor: 12.988

8.  Association of Bw46 and Cw1/Cw3 in Chinese.

Authors:  S H Chan; G B Wee
Journal:  Tissue Antigens       Date:  1979-08

9.  Possible evidence for a variant of myasthenia gravis based on HLA and acetylcholine receptor antibody in Chinese patients.

Authors:  B R Hawkins; Y L Yu; V Wong; E Woo; M S Ip; R L Dawkins
Journal:  Q J Med       Date:  1989-03

10.  HLA antigens in Japanese patients with myasthenia gravis.

Authors:  K Matsuki; T Juji; K Tokunaga; M Takamizawa; H Maeda; M Soda; Y Nomura; M Segawa
Journal:  J Clin Invest       Date:  1990-08       Impact factor: 14.808

View more
  8 in total

1.  Clinical and serological study of myasthenia gravis in HuBei Province, China.

Authors:  Xiaofan Zhang; Mingshan Yang; Jinzhi Xu; Min Zhang; Bethan Lang; Wei Wang; Angela Vincent
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-11-06       Impact factor: 10.154

2.  A cohort study on myasthenia gravis patients in China.

Authors:  Wei Wang; Yu-Ping Chen; Zhong-Kui Wang; Dong-Ning Wei; Ling Yin
Journal:  Neurol Sci       Date:  2013-02-20       Impact factor: 3.307

Review 3.  Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity.

Authors:  Matthew N Meriggioli; Donald B Sanders
Journal:  Lancet Neurol       Date:  2009-05       Impact factor: 44.182

4.  Characterization of CD4 and CD8 T cell responses in MuSK myasthenia gravis.

Authors:  J S Yi; A Guidon; S Sparks; R Osborne; V C Juel; J M Massey; D B Sanders; K J Weinhold; J T Guptill
Journal:  J Autoimmun       Date:  2013-12-28       Impact factor: 7.094

5.  Higher risk of myasthenia gravis in patients with thyroid and allergic diseases: a national population-based study.

Authors:  Jiann-Horng Yeh; Huang-Tsung Kuo; Hsuan-Ju Chen; Yen-Kung Chen; Hou-Chang Chiu; Chia-Hung Kao
Journal:  Medicine (Baltimore)       Date:  2015-05       Impact factor: 1.889

Review 6.  The Epidemiology and Phenotypes of Ocular Manifestations in Childhood and Juvenile Myasthenia Gravis: A Review.

Authors:  Jeannine M Heckmann; Tarin A Europa; Aayesha J Soni; Melissa Nel
Journal:  Front Neurol       Date:  2022-02-23       Impact factor: 4.003

7.  CTLA4 variants and haplotype contribute genetic susceptibility to myasthenia gravis in northern Chinese population.

Authors:  Liang Sun; Yunxiao Meng; Yanchen Xie; Hua Zhang; Zheng Zhang; Xiaoxia Wang; Bin Jiang; Wei Li; Yao Li; Ze Yang
Journal:  PLoS One       Date:  2014-07-08       Impact factor: 3.240

8.  Molecular and clinical relationship between live-attenuated Japanese encephalitis vaccination and childhood onset myasthenia gravis.

Authors:  Dan He; Han Zhang; Jun Xiao; Xiaofan Zhang; Minjie Xie; Dengji Pan; Minghuan Wang; Xiang Luo; Bitao Bu; Min Zhang; Wei Wang
Journal:  Ann Neurol       Date:  2018-09       Impact factor: 10.422

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.